发明名称 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
摘要 Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer. Similarly, provided is a method of treating cancer in a subject by increasing expression of DEFB1 in the subject, in the method wherein the expression of DEFB1 is increased, it can be increased by blocking the binding of PAX2 to the DEFB1 promoter. Blocking the binding of PAX2 to the DEFB1 promoter can be by administration of an oligonucleotide the PAX2 DNA binding site of DEFB1. This oligonucleotide can be complementary to the sequence of PAX2 that binds to the DEFB1 promoter. Alternatively, the oligonucleotide can interact with the PAX2 in a way that inhibits binding to DEFB1.
申请公布号 EP2395076(A1) 申请公布日期 2011.12.14
申请号 EP20110160862 申请日期 2006.10.16
申请人 MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 发明人 DONALD, CARLTON D., DR.
分类号 C12N5/00;A61K31/70;A61K38/17;C07K14/47;C12N5/02;C12N15/113;C12N15/115 主分类号 C12N5/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利